Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hubei Provincial Institute of Urology, Wuhan, China.
Int J Biol Sci. 2024 Mar 3;20(5):1905-1926. doi: 10.7150/ijbs.91480. eCollection 2024.
Increasing evidence suggests that autophagy plays a major role during renal fibrosis. Transcription factor EB (TFEB) is a critical regulator of autophagy- and lysosome-related gene transcription. However, the pathophysiological roles of TFEB in renal fibrosis and fine-tuned mechanisms by which TFEB regulates fibrosis remain largely unknown. Here, we found that TFEB was downregulated in unilateral ureteral obstruction (UUO)-induced human and mouse fibrotic kidneys, and kidney-specific TFEB overexpression using recombinant AAV serotype 9 (rAAV9)-TFEB in UUO mice alleviated renal fibrosis pathogenesis. Mechanically, we found that TFEB's prevention of extracellular matrix (ECM) deposition depended on autophagic flux integrity and its subsequent blockade of G2/M arrest in tubular cells, rather than the autophagosome synthesis. In addition, we together RNA-seq with CUT&Tag analysis to determine the TFEB targeted gene ATP6V0C, and revealed that TFEB was directly bound to the ATP6V0C promoter only at specific site to promote its expression through CUT&Run-qPCR and luciferase reporter assay. Interestingly, TFEB induced autophagic flux integrity, mainly dependent on scaffold protein ATP6V0C-mediated autophagosome-lysosome fusion by bridging with STX17 and VAMP8 (major SNARE complex) by co-immunoprecipitation analysis, rather than its mediated lysosomal acidification and degradation function. Moreover, we further investigated the underlying mechanism behind the low expression of TEFB in UUO-induced renal fibrosis, and clearly revealed that TFEB suppression in fibrotic kidney was due to DNMT3a-associated TFEB promoter hypermethylation by utilizing methylation specific PCR (MSP) and bisulfite-sequencing PCR (BSP), which could be effectively recovered by 5-Aza-2'-deoxycytidine (5A-za) to alleviate renal fibrosis pathogenesis. These findings reveal for the first time that impaired TFEB-mediated autophagosome-lysosome fusion disorder, tubular cell G2/M arrest and renal fibrosis appear to be sequentially linked in UUO-induced renal fibrosis and suggest that DNMT3a/TFEB/ATP6V0C may serve as potential therapeutic targets to prevent renal fibrosis.
越来越多的证据表明,自噬在肾纤维化过程中起着重要作用。转录因子 EB(TFEB)是自噬和溶酶体相关基因转录的关键调节因子。然而,TFEB 在肾纤维化中的病理生理作用以及 TFEB 调节纤维化的精细机制在很大程度上仍然未知。在这里,我们发现 TFEB 在单侧输尿管梗阻(UUO)诱导的人类和小鼠纤维化肾脏中下调,并且在 UUO 小鼠中使用重组腺相关病毒血清型 9(rAAV9)-TFEB 进行肾脏特异性 TFEB 过表达可减轻肾脏纤维化发病机制。在机制上,我们发现 TFEB 预防细胞外基质(ECM)沉积取决于自噬体流的完整性及其随后在管状细胞中阻止 G2/M 停滞,而不是自噬体合成。此外,我们将 RNA-seq 与 CUT&Tag 分析相结合,以确定 TFEB 的靶向基因 ATP6V0C,并揭示 TFEB 仅在特定位点直接结合到 ATP6V0C 启动子上,通过 CUT&Run-qPCR 和荧光素酶报告基因测定促进其表达。有趣的是,TFEB 诱导的自噬体流完整性主要依赖于支架蛋白 ATP6V0C 通过与 STX17 和 VAMP8(主要 SNARE 复合物)桥接来介导自噬体-溶酶体融合,而不是其介导的溶酶体酸化和降解功能。此外,我们进一步研究了 UUO 诱导的肾纤维化中 TFEB 低表达的潜在机制,并通过甲基化特异性 PCR(MSP)和亚硫酸氢盐测序 PCR(BSP)清楚地揭示了纤维化肾脏中 TFEB 抑制是由于 DNMT3a 相关的 TFEB 启动子过度甲基化,这可以通过 5-Aza-2'-脱氧胞苷(5A-za)有效地恢复,以减轻肾纤维化发病机制。这些发现首次表明,受损的 TFEB 介导的自噬体-溶酶体融合障碍、管状细胞 G2/M 停滞和肾纤维化似乎在 UUO 诱导的肾纤维化中依次相关,并表明 DNMT3a/TFEB/ATP6V0C 可能作为潜在的治疗靶点预防肾纤维化。